异构B细胞免疫调节疗法用于肌缩性侧面硬化症
Ruxandra F Sîrbulescu1,2, Katharine Nicholson3,2, Kento Kawai1
1Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
概括
哈普洛同一性B细胞疗法在肌缩性侧面硬化症 (ALS) 中表现有前途. 在小鼠模型和人类患者的输液证明了安全性,延迟了疾病的进展,并改善了生存率,这表明ALS的潜在新治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种神经退行性疾病,与免疫系统失调有关.
- 临床前研究表明B细胞可以采取神经保护作用 (pligodraxis).
研究的目的:
- 在ALS小鼠模型 (SOD1G93A) 中研究平分相同的B细胞输液的治疗潜力.
- 评估B细胞疗法的安全性和可行性,用于患有晚期ALS的人类患者.
主要方法:
- 在10周内向SOD1G93A小鼠静脉注射纯化脏成熟的原始B细胞.
- 在一个患有晚期ALS的人身上,从一个健康的单一捐赠者中输入CD19+ B细胞,两次在60天的时间间隔内输入.
主要成果:
- 在小鼠中,B细胞疗法显著延迟了疾病发病,延长了生存期,减少了亡,并减少了星结症.
- 在人类患者中,B细胞输液是安全的,没有明显的炎症反应,在ALSFRS-R尺度上有5个点的改善.
- 输液后的炎症标志物显示患者的持续减少.
结论:
- 单独的B细胞输液是对ALS的安全和可行的治疗策略.
- 这种方法在临床前的ALS模型中显示出有效性,在人类患者中显示出初始的积极结果.
- B细胞疗法代表了一种潜在的基于细胞的新疗法,用于肌缩性侧面硬化症.
更多相关视频
10:49Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
20.6K
09:36Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
Published on: June 23, 2022
3.4K
相关概念视频
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
